102 related articles for article (PubMed ID: 21045488)
1. A new method to classify pathologic grades of astrocytomas based on magnetic resonance imaging appearances.
Zhao ZX; Lan K; Xiao JH; Zhang Y; Xu P; Jia L; He M
Neurol India; 2010; 58(5):685-90. PubMed ID: 21045488
[TBL] [Abstract][Full Text] [Related]
2. Differentiating diffuse World Health Organization grade II and IV astrocytomas with ex vivo magnetic resonance spectroscopy.
Vettukattil R; Gulati M; Sjøbakk TE; Jakola AS; Kvernmo NA; Torp SH; Bathen TF; Gulati S; Gribbestad IS
Neurosurgery; 2013 Feb; 72(2):186-95; discussion 195. PubMed ID: 23147779
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between magnetic resonance diffusion weighted imaging and cell density in astrocytoma].
Chen J; Xia J; Zhou YC; Xia LM; Zhu WZ; Zou ML; Feng DY; Wang CY
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):309-11. PubMed ID: 15996330
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive grading of untreated gliomas: a comparative study of MR imaging and 3-(iodine 123)-L-alpha-methyltyrosine SPECT.
Riemann B; Papke K; Hoess N; Kuwert T; Weckesser M; Matheja P; Wassmann H; Heindel W; Schober O
Radiology; 2002 Nov; 225(2):567-74. PubMed ID: 12409596
[TBL] [Abstract][Full Text] [Related]
5. Microvascular permeability of brain astrocytoma with contrast-enhanced magnetic resonance imaging: correlation analysis with histopathologic grade.
Jia ZZ; Geng DY; Liu Y; Chen XR; Zhang J
Chin Med J (Engl); 2013; 126(10):1953-6. PubMed ID: 23673117
[TBL] [Abstract][Full Text] [Related]
6. Combined value of susceptibility-weighted and perfusion-weighted imaging in assessing who grade for brain astrocytomas.
Wang XC; Zhang H; Tan Y; Qin JB; Wu XF; Wang L; Zhang L
J Magn Reson Imaging; 2014 Jun; 39(6):1569-74. PubMed ID: 24987755
[TBL] [Abstract][Full Text] [Related]
7. Potential Utility of Visually AcceSAble Rembrandt Images Assessment in Brain Astrocytoma Grading.
Yu J; Wang M; Song J; Huang D; Hong X
J Comput Assist Tomogr; 2016; 40(2):301-6. PubMed ID: 26978002
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of transforming growth factor-beta 1 before and after removal of low- and high-grade astrocytomas.
Loh JK; Lieu AS; Su YF; Cheng CY; Tsai TH; Lin CL; Lee KS; Hwang SL; Kwan AL; Wang CJ; Hong YR; Chio CC; Howng SL
Cytokine; 2013 Feb; 61(2):413-8. PubMed ID: 23260996
[TBL] [Abstract][Full Text] [Related]
9. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
10. Serum protein fingerprinting coupled with artificial neural network distinguishes glioma from healthy population or brain benign tumor.
Liu J; Zheng S; Yu JK; Zhang JM; Chen Z
J Zhejiang Univ Sci B; 2005 Jan; 6(1):4-10. PubMed ID: 15593384
[TBL] [Abstract][Full Text] [Related]
11. [MR tomography of astrocytic tumors (I-III)].
Pedrosa P; Grigat M; Higer HP; Straube U; Schaeben W; Gutjahr P; Voth D; Kunze S
Rofo; 1989 Jan; 150(1):52-7. PubMed ID: 2536497
[TBL] [Abstract][Full Text] [Related]
12. MR spectroscopy differentiation between high and low grade astrocytomas: a comparison between paediatric and adult tumours.
Porto L; Kieslich M; Franz K; Lehrnbecher T; Zanella F; Pilatus U; Hattingen E
Eur J Paediatr Neurol; 2011 May; 15(3):214-21. PubMed ID: 21145271
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic imaging of high-grade astrocytoma: heterogeneity of clinical manifestation, image characteristics, and histopathological findings].
Okajima K; Ohta Y
Brain Nerve; 2012 Oct; 64(10):1151-7. PubMed ID: 23037605
[TBL] [Abstract][Full Text] [Related]
14. Dynamic susceptibility contrast perfusion weighted imaging in grading of nonenhancing astrocytomas.
Morita N; Wang S; Chawla S; Poptani H; Melhem ER
J Magn Reson Imaging; 2010 Oct; 32(4):803-8. PubMed ID: 20882610
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility-weighted imaging: the value in cerebral astrocytomas grading.
Zhang H; Tan Y; Wang XC; Qing JB; Wang L; Wu XF; Zhang L; Liu QW
Neurol India; 2013; 61(4):389-95. PubMed ID: 24005730
[TBL] [Abstract][Full Text] [Related]
16. Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method.
Murakami R; Hirai T; Sugahara T; Fukuoka H; Toya R; Nishimura S; Kitajima M; Okuda T; Nakamura H; Oya N; Kuratsu J; Yamashita Y
Radiology; 2009 Jun; 251(3):838-45. PubMed ID: 19318585
[TBL] [Abstract][Full Text] [Related]
17. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response.
Law M; Oh S; Babb JS; Wang E; Inglese M; Zagzag D; Knopp EA; Johnson G
Radiology; 2006 Feb; 238(2):658-67. PubMed ID: 16396838
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging characteristics of pilomyxoid astrocytoma.
Komotar RJ; Zacharia BE; Sughrue ME; Mocco J; Carson BS; Tihan T; Otten ML; Burger PC; Garvin JH; Khandji AG; Anderson RC
Neurol Res; 2008 Nov; 30(9):945-51. PubMed ID: 18662499
[TBL] [Abstract][Full Text] [Related]
19. An image-analysis system based on support vector machines for automatic grade diagnosis of brain-tumour astrocytomas in clinical routine.
Glotsos D; Spyridonos P; Cavouras D; Ravazoula P; Dadioti PA; Nikiforidis G
Med Inform Internet Med; 2005 Sep; 30(3):179-93. PubMed ID: 16403707
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy.
Fountas KN; Kapsalaki EZ; Vogel RL; Fezoulidis I; Robinson JS; Gotsis ED
Stereotact Funct Neurosurg; 2004; 82(2-3):90-7. PubMed ID: 15305081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
